Umbilical cord blood gifted to non-profit public cord blood banks is now routinely used as an alternative source of haematopoietic stem cells for allogeneic transplantation for children and adults with cancer, bone marrow failure syndromes, haemoglobinopathies and many genetic metabolic disorders. Because of the success and outcomes of public cord banking, many companies now provide private cord banking services. However, in the absence of any published transplant evidence to support autologous and non-directed family banking, commercial cord banks currently offer a superfluous service.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Barker, J. N. & Wagner, J. E. Umbilical-cord blood transplantation for the treatment of cancer. Nature Rev. Cancer 3, 526–532 (2003).
Gluckman, E. & Rocha, V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 7, 219–227 (2005).
Rubinstein, P. Why cord blood? Human Immunol. 67, 398–404 (2006).
Cord Blood Registry [online] (2007).
Annas, G. J. Waste and longing — The legal status of placental-blood banking. N. Engl. J. Med. 340, 1521–1524 (1999).
Burgio, G. R. & Locatelli, F. Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics. Bone Marrow Transplant. 19, 1163–1168 (1997).
Fisk, N. M., Roberts, I. A., Markwald, R. & Mironov, V. Can routine commercial cord blood banking be scientifically and ethically justified? PLoS Med. 2, e44 (2005).
Sugarman, J. et al. Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking. JAMA 278, 938–943 (1997).
American Academy of Pediatrics WGOCBB. Cord blood banking for potential future transplantation: subject review. American Academy of Pediatrics. Work Group on Cord Blood Banking. Pediatrics 104, 116–118 (1999).
Puigdomench-Rosell, P., Virt, G., for the European Group on Ethics in Science and New Technologies. Ethical aspects of umbilical cord blood banking. European Group on Ethics in Science and New Technologies, European Commission [online] (2004).
Barker, J. N. & Wagner, J. E. Umbilical cord blood transplantation: current practice and future innovations. Crit. Rev. Oncol. Hematol. 48, 35–43 (2003).
Benito, A. I., Diaz, M. A., Gonzalez-Vicent, M., Sevilla, J. & Madero, L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant. 33, 675–690 (2004).
Eapen, M. et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. [see comment] Lancet 369, 1947–1954 (2007).
Hwang, W. Y. et al. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol. Blood Marrow Transplant. 13, 444–453 (2007).
Laughlin, M. J. et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351, 2265–2275 (2004).
Mao, P. et al. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy. Bone Marrow Transplant. 33, 33–38 (2004).
Ooi, J. et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 103, 489–491 (2004).
Ooi, J. et al. Unrelated cord blood transplantation for adult patients with acute lymphoblastic leukemia. Leukemia 18, 1905–1907 (2004).
Rocha, V. et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97, 2962–2971 (2001).
Rubinstein, P. & Stevens, C. E. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Bailliere's Best Pract. Clin. Haematol. 13, 565–584 (2000).
Rubinstein, P. et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339, 1565–1577 (1998).
American Academy of Pediatrics Section on Hematology Oncology, American Academy of Pediatrics Section on allergy Immunology, Lubin, B. H. & Shearer, W. T. Cord blood banking for potential future transplantation. Pediatrics 119, 165–170 (2007).
Armson, B. A. & Maternal/Fetal Medicine Committee SOOAGOC. Umbilical cord blood banking: implications for perinatal care providers. J. Obstet. Gynaecol. Can. 27, 263–290 (2005) [erratum appears in J. Obstet. Gynaecol. Can. 27, 673].
Eaton, L. Many cord blood banks' claims are unfounded, says Royal College. BMJ 332, 1411 (2006).
Edozien, L. C. NHS maternity units should not encourage commercial banking of umbilical cord blood. BMJ 333, 801–804 (2006) [see comment].
Kurtzberg, J., Lyerly, A. D. & Sugarman, J. Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J. Clin. Invest. 115, 2592–2597 (2005).
Steinbrook, R. The cord-blood-bank controversies. N. Engl. J. Med. 351, 2255–2257 (2004).
Sullivan, M., Browett, P. & Patton, N. Private umbilical cord blood banking: a biological insurance of dubious future benefit! N. Z. Med. J. 118, U1260 (2005) [see comment].
van Rood, J. J. & Oudshoorn, M. Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment? Bone Marrow Transplant. 41, 1–9 (2008).
Rocha, V. & Locatelli, F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 41, 207–214 (2008).
Gluckman, E. et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174–1178 (1989).
Wall, D. A. Issues in the quality of umbilical cord blood stem cells for transplantation: challenges in cord blood banking quality management. Transfusion 45, 826–828 (2005).
Anonymous. Umbilical cord blood banking Richard Branson's way. Lancet 369, 437 (2007).
Garderet, L. et al. The umbilical cord blood αβ T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 91, 340–346 (1998).
Rocha, V. et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342, 1846–1854 (2000).
Rocha, V., Gluckman, E. & Eurocord and European Blood and Marrow Transplant Group. Clinical use of umbilical cord blood hematopoietic stem cells. Biol. Blood Marrow Transplant. 12, 34–41 (2006).
Schoemans, H. et al. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant. 38, 83–93 (2006).
Broxmeyer, H. E. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 7, 209–218 (2005).
Wexler, S. A. et al. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br. J. Haematol. 121, 368–374 (2003).
He, Q., Wan, C. & Li, G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25, 69–77 (2007).
Lennard, A. L. & Jackson, G. H. Stem cell transplantation. BMJ 321, 433–437 (2000). [erratum appears in BMJ 321, 1331]
Prasad, V. K. & Kurtzberg, J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 41, 99–108 (2008).
Gluckman, E. & Wagner, J. E. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant. 41, 127–132 (2008).
Bhatia, M. & Walters, M. C. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 41, 109–117 (2008).
Dvorak, C. C. & Cowan, M. J. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant. 41, 119–126 (2008).
Hahn, T. et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. Biol. Blood Marrow Transplant. 11, 823–861 (2005).
Copelan, E. A. Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813–1826 (2006) [see comment].
Carella, A. M. & Bregni, M. Current role of allogeneic stem cell transplantation in breast cancer. Ann. Oncol. 18, 1591–1593 (2007).
Rocha, V. et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351, 2276–2285 (2004).
Ferreira, E., Pasternak, J., Bacal, N., de Campos Guerra, J. C. & Mitie Watanabe, F. Autologous cord blood transplantation. Bone Marrow Transplant 24, 1041 (1999).
Friedrich, M. J. Growing role for umbilical cord blood. JAMA 292, 2453–2454 (2004).
Hayani, A., Lampeter, E., Viswanatha, D., Morgan, D. & Salvi, S. N. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119, e296–300 (2007).
Fish., J. D. & Grupp, S. A. Stem cell transplantation for neuroblastoma. Bone Marrow Transplant. 41, 159–165 (2008).
Philip, T. et al. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party. Eur. J. Cancer 33, 2130–2135 (1997).
Hartmann, O. et al. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: A multivariate analysis in 218 patients treated in a single institution. Bone Marrow Transplant. 23, 789–795 (1999).
George, R. E. et al. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J. Clin. Oncol. 24, 2891–2896 (2006).
Burdach, S. et al. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann. Oncol. 11, 1451–1462 (2000).
Burke, M. J., Walterhouse, D. O., Jacobsohn, D. A., Duerst, R. E. & Kletzel, M. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors. Pediatric Blood Cancer 49, 196–198 (2007) [see comment].
Dunkel, I. J. & Finlay, J. L. High-dose chemotherapy with autologous stem cell rescue for brain tumors. Critical Rev. Oncol. Hematol. 41, 197–204 (2002).
Fagioli, F. et al. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors. Cancer 100, 2215–2221 (2004).
Lin, T. S. & Copelan, E. A. Autologous stem cell transplantation for non-Hodgkin's lymphoma. Curr. Hematol. Rep. 2, 310–315 (2003).
Meyers, P. A. et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J. Clin. Oncol. 19, 2812–2820 (2001).
Thorarinsdottir, H. K. et al. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Pediatric Blood Cancer 48, 278–284 (2007).
Bradley, M. B. & Cairo, M. S. Stem cell transplantation for pediatric lymphoma: past, present and future. Bone Marrow Transplant. 41, 149–158 (2008).
Marachelian, A., Butturini, A. & Finlay, J. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors. Bone Marrow Transplant. 41, 167–172 (2008).
Kremens, B. et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant. 30, 893–898 (2002).
Fagioli, F. et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J. Clin. Oncol. 20, 2150–2156 (2002).
Koscielniak, E. et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant. 19, 227–231 (1997).
Urban, C. et al. Autologous cord blood transplantation in a child with acute lymphoblastic leukemia and central nervous system relapse [comment]. Pediatrics 119, 1042–1043; author reply 1043 (2007).
Zipursky, A. Fetal origin of leukemia and autologous cord blood transfusions. Pediatric Res. 47, 574 (2000).
Ando, T. et al. Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation. Leukemia 20, 744–745 (2006) [see comment].
Fraser, C. J. et al. First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood 106, 4377–4380 (2005).
Greaves, M. Cord blood donor leukaemia in recipients. Leukemia 20, 1633–1664 (2006).
Matsunaga, T., et al. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am. J. Hematol. 79, 294–298 (2005).
Greaves, M. Pre-natal origins of childhood leukemia. Rev. Clin. Exp. Hematol. 7, 233–245 (2003).
Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nature Rev. Cancer 3, 1–11 (2003).
Mori, H. et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 8242–8247 (2002).
Biernaux, C., Loos, M., Sels, A., Huez, G. & Stryckmans, P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86, 3118–3122 (1995).
Biernaux, C., Sels, A., Huez, G. & Stryckmans, P. Very low level of major BCR–ABL expression in blood of some healthy individuals. Bone Marrow Transplant. 17 (Suppl. 3), S45–47 (1996).
Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M. & Melo, J. V. The presence of typical and atypical BCR–ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92, 3362–3367 (1998).
Pasquini, M. C., Logan, B. R., Verter, F., Horowitz, M. M. & Nietfeld, J. J. The likelihood of hematopoietic stem cell transplantation (HCT) in the United States: implications for umbilical cord blood storage. ASH Ann. Meeting Abstracts 106, 1330 (2005).
Johnson, F. L. Placental blood transplantation and autologous banking — caveat emptor. J. Pediatric Hematol. Oncol. 19, 183–186 (1997).
Kline, R. D. Whose blood is it, anyway. Sci. Am. 4, 30–37 (2001).
Stiller, C. A. et al. Cancer incidence and survival in European adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur. J. Cancer 42, 2006–2018 (2006).
Stiller, C. A. et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997 Report from the Automated Childhood Cancer Information System project. Eur. J. Cancer 42, 1952–1960 (2006).
Spix, C., Pastore, G., Sankila, R., Stiller, C. A. & Steliarova-Foucher, E. Neuroblastoma incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur. J. Cancer 42, 2081–2091 (2006).
Armand, P. & Antin, J. H. Allogeneic stem cell transplantation for aplastic anemia. Biol. Blood Marrow Transplant. 13, 505–516 (2007).
Fruchtman, S. M. et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol. Blood Marrow Transplant. 10, 741–742 (2004).
American College of Obstetricians and Gynecologists. Routine storage of umbilical cord blood for potential future transplantation. Int. J. Gynaecol. Obstet. 58, 257–259 (1997).
French National Consultative Ethics Committee for Health and Life Sciences. Umbilical cord blood banks for autologous use or for research. Opinion number 74 [online] (2002).
Royal College of Obstetricians and Gynaecologists Scientific Advisory Committee. Umbilical cord blood banking. Opinion paper 2 revised [online] (2006).
Grewal, S. S., Kahn, J. P., MacMillan, M. L., Ramsay, N. K. & Wagner, J. E. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 103, 1147–1151 (2004).
Mazur, M., Kurtzberg, J., Halperin, E., Ciocci, G. & Szabolcs, P. Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J. Pediatric Hematol. Oncol. 28, 840–844 (2006).
Picardi, A. et al. Unrelated cord blood transplantation for children with high risk myelodysplastic syndromes. Haematologica 89, ELT08 (2004).
Yesilipek, M. A. Stem cell transplantation in hemoglobinopathies. Hemoglobin 31, 251–256 (2007).
Cibelli, J. Development: Is therapeutic cloning dead? Science 318, 1879–1880 (2007).
Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39–49 (2007).
Maherali, N., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).
Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).
Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007) [see comment].
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
The author thanks R. Corbett, A. Turnbull and S. Beasley for their support and advice.
American Society for Blood and Marrow Transplantation (ASBMt)
Bone Marrow Donors Worldwide (BMDW)
Caitlin Raymond International Registry
Center for International Blood and Marrow Transplant Research (CIRBMT)
European Group for Blood and Marrow Transplantation (EBMT)
Foundation for Accreditation of Cellular Therapies (FACT)
National Marrow Donor Program (NMDP)
World Marrow Donor Association
National Cancer Institute
Rights and permissions
About this article
Cite this article
Sullivan, M. Banking on cord blood stem cells. Nat Rev Cancer 8, 555–563 (2008). https://doi.org/10.1038/nrc2418
This article is cited by
Drivers of consumers’ behavioral intention toward private umbilical cord blood banking: a review
Cell and Tissue Banking (2022)
Stem Cell Therapy: Challenges Ahead
The Indian Journal of Pediatrics (2015)